Browsing Tag
Evercore
19 posts
Teledyne Technologies to acquire Varex Imaging, adding photon counting X-ray detectors to its imaging portfolio
Teledyne is paying a 52% premium for Varex Imaging, taking the only independent commercial photon counting CT detector supplier as OEMs race to catch Siemens.
Prologis agrees £14.3bn SEGRO takeover in largest 2026 UK REIT deal
Prologis will pay up to £14.3 billion for SEGRO, but H1 2027 closing hinges on shareholder votes, regulatory clearances and a fresh $2.1bn equity raise.
Kimbell Royalty Partners (NYSE: KRP) to buy $215.4m royalty portfolio across four basins
Kimbell Royalty Partners agrees a US$215.4 million four-basin royalty acquisition as production growth, dilution and leverage come into focus.
Rambus (RMBS) launches DDR5 9600 Server RDIMM chipset with 20% bandwidth gain
Rambus (RMBS) launches DDR5 9600 Server RDIMM chipset for AI data centers, 20% bandwidth gain. Q2 fiscal 2026 earnings July 27 as memory interface scales.
Could Rocket Lab’s $8bn Iridium deal redefine its space growth story?
Rocket Lab’s $8 billion Iridium deal could transform RKLB into a vertically integrated space company with launch, satellites, spectrum and recurring services.
Beazley (LSE: BEZ) edges up 0.04% on Friday with Zurich scheme on glide path to court sanction and H2 completion
Beazley shareholders voted 99.9% in favour. Zurich keeps buying at 1,280p. The court hearing is next. The 2.3% arbitrage spread is the last word on this deal.
Arm Performix launches as Arm Holdings (NASDAQ: ARM) extends agentic AI play beyond silicon
Arm built the silicon. Now it wants to own the optimisation layer above it. Performix is free, agent-ready, and aimed squarely at the x86 migration question.
FORVIA agrees to sell Interiors unit to Apollo Funds for €1.8bn in IGNITE strategy push
FORVIA to sell Interiors to Apollo at 3.1x EBITDA. The €1.82bn deal cuts debt by €1bn but reveals how cheaply European suppliers must now sell scale.
Thermo Fisher (NYSE: TMO) to offload Remel and Oxoid microbiology arm in $1bn Astorg deal
Thermo Fisher is selling a 95% recurring revenue microbiology business near its trading lows. The real question is what Marc Casper plans to do with the cash.
WBD stock sits near $27 as $31 Paramount offer clears shareholder vote: Inside the merger arb gap and regulatory risk
WBD shareholders approve $110bn Paramount Skydance takeover. What the deal means for Hollywood, media consolidation, and the regulatory road ahead.